Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03802656 · ClinicalTrials.gov registry record · NA

Vertebral Body Tethering Treatment for Idiopathic Scoliosis

A NA study, sponsored by Ochsner Health System.

Terminated
Registry status
NA
Development phase
2
Enrollment target

NCT03802656: Clinical Trial NA study, sponsored by Ochsner Health System.

NCT03802656 is a NA study that was terminated before completion, run by Ochsner Health System. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03802656, a NA study, was terminated before completion, sponsored by Ochsner Health System.

TERMINATED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

This study will determine whether vertebral body tethering is a safe and feasible method of treatment for pediatric idiopathic scoliosis.

Primary Outcome

Intraoperative and post-intervention medical events or signs and symptoms of complications arising after the start of study intervention will be captured. The event description, date of onset, end date, severity, and outcome will be documented. The frequencies, type, body system, severity, and relationship to the study intervention will also be summarized. A distinction will be made between those events which are "device-related" and "non device-related".

Interventions

  • DEVICE Anterior Vertebral Body Tethering

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2019-06-24
Est. Completion 2019-12-12
Phase NA
Ochsner Health System

29 total trials

Why NCT03802656 stopped before completion

NCT03802656 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Anterior Vertebral Body Tethering is the first listed.

NCT03802656 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03802656 about?

NCT03802656 is a clinical study titled "Vertebral Body Tethering Treatment for Idiopathic Scoliosis". This study will determine whether vertebral body tethering is a safe and feasible method of treatment for pediatric idiopathic scoliosis.

What is the current status of trial NCT03802656?

This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2019-06-24. Estimated completion is 2019-12-12.

What interventions are being tested in trial NCT03802656?

The interventions under investigation include: Anterior Vertebral Body Tethering (DEVICE).

Who is sponsoring clinical trial NCT03802656?

This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03802656's enrollment target sits among peer trials

2 1997th of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03802656, the US trial registry maintained by the National Library of Medicine. NCT03802656 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.